Phase to Phase: The Guide to Drug Development

Phase to Phase: The Guide to Drug Development

Sponsored by Thermo Fisher Scientific and PPD, experts will present innovative strategies in outsourcing discovery that allows small companies to focus on their core discovery needs and frees them up from both a capital and manpower investment.

Session Topic: Diving into Phase 2 Clinical Trials

  • This stage is crucial for development of new treatments to ensure safety and efficacy for a specific indication.
  • Typically involve 25-100 patients with narrow enrollment criteria to assess the treatment in a relatively homogenous patient population.
  • Proof of concept is main goal and will determine Phase 3 go or no-go decision.

Heather Bryson, Executive Director, Strategic Development Consulting, PPD, part of Thermo Fisher Scientific
Jill Parris, Senior Director, Clinical Science, PPD, part of Thermo Fisher Scientific
Nikolay Stoyanov, Senior Director Clinical Science, Hematology/Oncology, PPD, part of Thermo Fisher Scientific

Get Updates
from LSPA

Stay up-to-date on the latest news and events from Life Sciences PA, insights from the life sciences industry,  and so much more!


Life Sciences Pennsylvania was founded in 1989 by a biotech scientist at Penn State University.  Today it has grown to represent the entire life sciences industry – medical device companies, pharmaceutical companies, investment organizations, research institutions, and myriad service industries that support the life sciences in Pennsylvania.

Reach Out to us

411 Swedeland Road
Suite 23-1080
King of Prussia, PA 19406